Form 4: Jaguar Health CEO Lisa Conte Reports Changes in Beneficial Ownership
SEC Filing
Lisa Conte, CEO and President of Jaguar Health, reports the acquisition and disposal of common stock and restricted stock units.
Summary
- Lisa Conte, CEO and President of Jaguar Health, filed a Form 4 detailing changes in her beneficial ownership of the company's securities.
- On April 5, 2024, Conte acquired 600 shares of common stock and disposed of 4,600 shares.
- She also acquired 600 restricted stock units that convert into common stock on a one-for-one basis.
- These restricted stock units were granted on April 5, 2021, and vest in three equal annual installments beginning on April 5, 2022.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders.
Stakeholder Impact
- The filing provides shareholders with information about the CEO's stake in the company.
Key Dates
| Date | Description |
|---|---|
| 09/08/2021 | Issuer effected a 3-for-1 reverse stock split. |
| 04/05/2021 | Restricted stock units were granted. |
| 04/05/2022 | First vesting date of restricted stock units. |
| 01/23/2023 | Issuer effected a 75-for-1 reverse stock split. |
| 04/05/2024 | Transaction date for common stock and restricted stock units. |
| 04/17/2024 | Date of signature for the Form 4 filing. |
Keywords
Form 4, beneficial ownership, Jaguar Health, Lisa Conte, restricted stock units, common stock, JAGX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.